The U.S. is ready to roll out the COVID vaccine once it’s approved for kids age 5-11

hide caption

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on Oct. 1, in San Rafael, Calif

toggle caption

. Justin Sullivan/Getty Images

Justin Sullivan/Getty Images

The White House said on Wednesday that it is ready to quickly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age is licensed by the Food and Drug Administration and suggested by the Centers for Disease Control and Prevention. The administration has actually purchased enough doses for all 28 million children in that age and will offer it in smaller sized plans with necessary supplies like smaller sized needles to make it easier to get to doctors, pediatricians and community health centers, Biden administration authorities stated. “Should the FDA and CDC authorize the vaccine, we will be prepared to get shots in arms,” said White House coronavirus reaction coordinator Jeff Zients during a news instruction Wednesday early morning.

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on Oct. 1, in San Rafael, Calif

The White House stated on Wednesday that it is all set to quickly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is licensed by the Food and Drug Administration and advised by the Centers for Disease Control and Prevention. The vaccine could be cleared for usage in kids ages 5 to 11 within a couple of weeks, authorities said. White House officials stated they were announcing the plan to inoculate kids ages 5 to 11 prior to the vaccine was approved for that age group so they might be “operationally ready” to release the dosages as quickly as the approval came.

. Justin Sullivan/Getty Images

Under the plan, the administration will work with state and regional leaders to make the vaccine offered at more than 25,000 pediatricians offices and primary care sites and 100 childrens healthcare facility systems as well as drug stores, schools and neighborhood health. “Thats why were making sure that its trusted messengers with scientific reliability who go out there and talk about these vaccines,” Murthy said.

The vaccine might be cleared for use in kids ages 5 to 11 within a number of weeks, authorities stated. The FDAs independent advisory committee conference is set up for Oct. 26, and the CDCs independent advisory committee meeting is set for Nov. 2 and 3. The Pfizer vaccine currently has full approval for use in grownups, and the federal government has actually authorized it for emergency use in kids ages 12 to 17. White House officials said they were announcing the strategy to inoculate kids ages 5 to 11 before the vaccine was approved for that age so they might be “operationally prepared” to deploy the dosages as quickly as the approval came.

Leave a Reply

Your email address will not be published. Required fields are marked *